Ipsen is entering an exciting new era as a leading global biopharmaceutical company committed to delivering innovation for patient care with a goal of launching at least one new molecular entity or meaningful indication each year. Global partnerships are critical to achieve this transformation and have become the most important driver of our next phase of growth.
We have a strong foundation to build upon with 5,400 employees and products registered in over 100 countries with the U.S. being our fastest growing market.
Ipsen also has an outstanding partnership track record, progressing partnered products through global development and maximizing their value by expanding indications and opening new markets. We work with our partners to define a shared vision to unlock the full potential of their products, achieving mutual success for our partners and Ipsen. You will also find that our commitment, financial resources and size allow us to be flexible and creative in transactions.
If you have drug candidates that help patients with cancer and rare diseases or innovations that can build on our expertise in neurotoxins, we want to partner with you – because patients can’t wait.
Welcome
Why Ipsen
Deals & Partnerships
We craft flexible, innovative partnerships and structure agreements with emerging, like-minded companies. Our goal is to foster solutions, advance science and deliver new therapies.
Our approaches include:
Deals & Partnerships
Featured Deal
Ipsen is committed to investing in and advancing scientific innovation to deliver impactful new therapies for people and their families affected by cancer, neurological and rare diseases. We acquired Clementia Pharmaceuticals with the goal of bolstering our portfolio and expertise in rare diseases. Clementia and Ipsen have a shared commitment to developing and delivering innovative treatments for people living with debilitating or life-threatening rare conditions and supporting them and their families throughout their entire journey. We look forward to progressing the candidates acquired in this agreement through both clinical and regulatory pathways.
Featured Deal
Global Partnering Focus
Neuroscience
- Novel neurotoxins
- Technologies and solutions to enhance IPSEN’s botulinum toxin therapies and R&D capabilities
- Movement discoders, spasticity and adjacencies
Consumer HealthCare
- Strong regional OTx brand, or a basket of assets for building a second pillar within our portfolio
- Commercial infrastructure in Germany & Spain
- Prescription drugs, especially in France and China, to leverage our current capabilities in medical promotion
Our Partnering Philosophy
Your innovations and partnership are integral to our success
Successful partnerships start with a clear and transparent process that ultimately leads to developing common goals. We view every partnership opportunity as unique and our partnering process is customized to your asset and what you are looking for in a partnership with Ipsen. We aim to build a relationship with you through our partnering process.
We are diligent in assessment and exploration of new opportunities
In general, we begin our partnering process with you by ensuring your program is matched with a specialist in our External Innovation team with appropriate expertise for initial assessment at a non-confidential level.
If we are aligned on the key aspects pertaining to the potential of your program, its fit with Ipsen’s strategy and our mutual objectives of a partnership, we would progress our discussion under a confidentiality agreement to further our understanding of your program and partnering objectives, and your appreciation of what value Ipsen can bring as a partner. Our integrated team of experts will work closely with you to evaluate your confidential data and the potential of your program in detail. Our Global Business Development specialist will engage with you fully to explore a partnership structure that is mutually beneficial.
We have an engaged and transparent approach to partnering
Our unique combination of size, scope and expertise as a global biopharmaceutical company with a biotech mindset enables us to be decisive, competitive and creative in our partnering process. We conduct a transparent process and will stay fully engaged with you along the way.
When you partner with Ipsen, you will work with a dedicated member of our Alliance Management team with a relationship-focused and solution-based approach to partnership management.
Connect with us today
If your asset or technology fits within one of our core areas of focus, we want to talk to you. Please contact our team or meet us at one of our upcoming events.
Our Partnering Philosophy
Alliance Management
When you partner with Ipsen, you will work with a dedicated member of our Alliance Management team with a relationship-focused and solution-based approach to partnership management.
